Building on the 2025 National Academies Pharmacy Workshop: health systems financially supported pharmacist roles
Open Access
- 7 August 2026
- journal article
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (9)
Abstract
Pharmacist services demonstrate a positive impact on healthcare delivery, patient outcomes, and cost of care. Translating this evidence into sustainable funding models demands significant change in healthcare policy and payment that accounts for institutional constraints, payment structures, and scalability requirements. Meanwhile, the gap grows between the positive impact of pharmacist services and reimbursement limited to narrowly defined services or drug product costs. Lack of federally designated provider status and payer-imposed cost containment strategies threaten the financial sustainability of pharmacist services. Future solutions include innovative value-based payment with quality-driven reimbursement, comprehensive medication and care management, and shared financial savings linked to outcomes. Priority funding areas using a shared-savings model include acute and chronic care service lines that cater to high-acuity patients who require high-cost medications and experience frequent care transitions. This model is based on reductions in medication costs, adverse drug-related outcomes, length of stay, and readmissions. A call to action is proposed, focused on policy changes in provider status, adequate payer reimbursement, improving current fee-for-service models and shifting payment models to value-based payment, and removing misaligned financial strategies.Keywords
This publication has 48 references indexed in Scilit:
- National Assessment of Reimbursement Models for Clinical Faculty Services in Academic Pharmacy PracticeJACCP: Journal of the American College of Clinical Pharmacy, 2025
- Potential US Health Care Savings Based on Clinician Views of Feasible Site-of-Care ShiftsJAMA Network Open, 2024
- State of the union: A review of state‐based laws and regulations supporting pharmacist payment for clinical servicesJACCP: Journal of the American College of Clinical Pharmacy, 2024
- Identifying ideal pharmacist‐to‐patient ratios for the successful provision of clinical pharmacy servicesJACCP: Journal of the American College of Clinical Pharmacy, 2024
- Outcomes of the 340B Drug Pricing ProgramJAMA Health Forum, 2023
- Risks to the 340B Drug Pricing Program Related to Manufacturer Restrictions on Drug AvailabilityJAMA, 2022
- Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospitalInternational Journal of Clinical Pharmacy, 2018
- Evidence of clinical and economic impact of pharmacist interventions related to antimicrobials in the hospital settingEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Impact of pharmacist involvement in the transitional care of high‐risk patients through medication reconciliation, medication education, and postdischarge call‐backs (IPITCH Study)Journal of Hospital Medicine, 2015
- Improving Care Transitions: Current Practice and Future Opportunities for PharmacistsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012